Q. Ping Dou

24.9k total citations · 3 hit papers
280 papers, 17.8k citations indexed

About

Q. Ping Dou is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Q. Ping Dou has authored 280 papers receiving a total of 17.8k indexed citations (citations by other indexed papers that have themselves been cited), including 176 papers in Molecular Biology, 127 papers in Oncology and 59 papers in Pathology and Forensic Medicine. Recurrent topics in Q. Ping Dou's work include Ubiquitin and proteasome pathways (105 papers), Cancer-related Molecular Pathways (58 papers) and Tea Polyphenols and Effects (43 papers). Q. Ping Dou is often cited by papers focused on Ubiquitin and proteasome pathways (105 papers), Cancer-related Molecular Pathways (58 papers) and Tea Polyphenols and Effects (43 papers). Q. Ping Dou collaborates with scholars based in United States, China and Hong Kong. Q. Ping Dou's co-authors include Huanjie Yang, Di Chen, Qiuzhi Cindy Cui, Vesna Milacic, Sara M. Schmitt, Kristin R. Landis‐Piwowar, Michael Frezza, Tak Hang Chan, David M. Smith and Benyi Li and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Q. Ping Dou

277 papers receiving 17.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bortezomib as the First Proteasome Inhibitor Anticancer Drug: Current Status and Future Perspectives

2011 640 citations Michael Frezza, Sara M. Schmitt et al. Current Cancer Drug Targets profile →
Disulfiram, a Clinically Used Anti-Alcoholism Drug and Copper-Binding Agent, Induces Apoptotic Cell Death in Breast Cancer Cultures and Xenografts via Inhibition of the Proteasome Activity

2006 572 citations Qiuzhi Cindy Cui, Huanjie Yang et al. Cancer Research profile →
Novel Metals and Metal Complexes as Platforms for Cancer Therapy

2010 462 citations Michael Frezza, S.S. Hindo et al. Current Pharmaceutical Design profile →

Peers

Countries citing papers authored by Q. Ping Dou

Since Specialization

Citations

This map shows the geographic impact of Q. Ping Dou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Q. Ping Dou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Q. Ping Dou more than expected).

Fields of papers citing papers by Q. Ping Dou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Q. Ping Dou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Q. Ping Dou. The network helps show where Q. Ping Dou may publish in the future.

Co-authorship network of co-authors of Q. Ping Dou

This figure shows the co-authorship network connecting the top 25 collaborators of Q. Ping Dou. A scholar is included among the top collaborators of Q. Ping Dou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Q. Ping Dou. Q. Ping Dou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	FreqWave-TranDuD: A Multivariate Time Series Anomaly Detection Method Based on Wavelet and Fourier Transforms 2025 ·IEEE Access ·Y. H. Huang, Peishun Liu, (unknown), Yin Tian, Q. Ping Dou, (unknown), (unknown)	1
2	Immune Checkpoint Inhibitor–Induced Ureteritis and Cystitis in Patients With Lung Cancer and Uterine Malignancies: A Case Series and Literature Review 2025 ·Journal of Immunotherapy ·Yan Yu, Q. Ping Dou, Xuefei Wu, Xiaotong Zhang, Xiaoyan Liu, Xiaoyan Si, Li Zhang	1
3	Multimodal ultrasound: a non-invasive method for identifying dedifferentiation of papillary thyroid carcinoma during active surveillance 2025 ·Frontiers in Oncology ·Q. Ping Dou, (unknown), Weimin Qiu, Ming Xu, Shuling Chen, Xiaoer Zhang, Xiaoyan Xie, Jinyu Liang	0
4	Effect of NaCl on the structural properties, hydrolytic properties and binding of heptanal of oxidized myofibrillar proteins 2025 ·International Journal of Biological Macromolecules ·Xia Hu, (unknown), Ziyi Zhang, Q. Ping Dou, Baohua Kong, Haotian Liu, Qian Chen	0
5	MicroRNAs as novel molecular targets of green tea polyphenol epigallocatechin-3-gallate (EGCG): relevance and importance to nutrition sciences and cancer prevention 2024 ·Food Science and Human Wellness ·Yu Li, Q. Ping Dou, Bo Li, Yongli Wang, Xiaolin Wang, Hui Guan, Dapeng Li, Li Feng	3
6	Striatins and STRIPAK complex partners in clinical outcomes of patients with breast cancer and responses to drug treatment 2023 ·Chinese Journal of Cancer Research ·(unknown), (unknown), Tracey A. Martin, Lin Ye, Fiona Ruge, Andrew J. Sanders, (unknown), Q. Ping Dou, Eleri Davies, Wen G. Jiang	7
7	Small molecules as antagonists of co-inhibitory pathways for cancer immunotherapy: a patent review (2018-2019) 2020 ·Expert Opinion on Therapeutic Patents ·(unknown), (unknown), (unknown), Peifu Jiao, Q. Ping Dou	8
8	An Updated Review of Disulfiram: Molecular Targets and Strategies for Cancer Treatment 2019 ·Current Pharmaceutical Design ·Qingzhu Yang, (unknown), Kai Li, Lin Jiao, Jiazhen Zhu, (unknown), (unknown), Q. Ping Dou, Huanjie Yang	33
9	Biological and Mechanistic Characterization of Novel Prodrugs of Green Tea Polyphenol Epigallocatechin Gallate Analogs in Human Leiomyoma Cell Lines 2016 ·Journal of Cellular Biochemistry ·(unknown), Gang Liu, Andrea Renzetti, Pershang Farshi, Huanjie Yang, (unknown), Ghassan M. Saed, (unknown), Hossny A. El-Banna, (unknown), Tak Hang Chan, Q. Ping Dou	30
10	Overview of Proteasome Inhibitor-Based Anti-cancer Therapies: Perspective on Bortezomib and Second Generation Proteasome Inhibitors versus Future Generation Inhibitors of Ubiquitin-Proteasome System 2014 ·Current Cancer Drug Targets ·Q. Ping Dou, Jeffrey A. Zonder	222
11	Inhibition of the 26S proteasome as a possible mechanism for toxicity of heavy metal species 2014 ·Journal of Inorganic Biochemistry ·Dajena Tomco, Sara M. Schmitt, Mary Jane Heeg, Q. Ping Dou, Cláudio N. Verani	2
12	Gambogic Acid Induces Apoptosis in Imatinib-Resistant Chronic Myeloid Leukemia Cells via Inducing Proteasome Inhibition and Caspase-Dependent Bcr-Abl Downregulation 2013 ·Clinical Cancer Research ·Xianping Shi, Xin Chen, Xiaofen Li, Xiaoying Lan, Chong Zhao, Shouting Liu, Hongbiao Huang, Ningning Liu, Siyan Liao, Wenbin Song, Ping Zhou, Shunqing Wang, Li Xu, Xuejun Wang, Q. Ping Dou, Jinbao Liu	114
13	Correction: Withaferin A Inhibits the Proteasome Activity in Mesothelioma In Vitro and In Vivo 2013 ·PLoS ONE ·Huanjie Yang, Ying Wang, (unknown), Wenjuan Wu, (unknown), Lisa Polin, Harvey I. Pass, Q. Ping Dou, Arun K. Rishi, Anil Wali	1
14	Cellular and computational studies of proteasome inhibition and apoptosis induction in human cancer cells by amino acid Schiff base–copper complexes 2012 ·Journal of Inorganic Biochemistry ·Jian Zuo, Caifeng Bi, Yuhua Fan, Daniela Buac, Chiara Nardon, Kenyon G. Daniel, Q. Ping Dou	95
15	Disulfiram Treatment Facilitates Phosphoinositide 3-Kinase Inhibition in Human Breast Cancer Cells In vitro and In vivo 2010 ·Cancer Research ·Haijun Zhang, Di Chen, (unknown), Wei Chen, Qiuzhi Cindy Cui, Stephen P. Ethier, Q. Ping Dou, Guojun Wu	94
16	Molecular Mechanisms of Green Tea Polyphenols 2009 ·Nutrition and Cancer ·Q. Ping Dou	50
17	Metals in anticancer therapy: Copper(II) complexes as inhibitors of the 20S proteasome 2009 ·European Journal of Medicinal Chemistry ·S.S. Hindo, Michael Frezza, Dajena Tomco, Mary Jane Heeg, L.M. Hryhorczuk, Bruce R. McGarvey, Q. Ping Dou, Cláudio N. Verani	87
18	Role of Ubiquitin-proteasome proteolytic pathway in malignant pleural mesothelioma. 2007 ·Cancer Research ·Anil Wali, Ying Wang, (unknown), Zhandong Liu, Sunita Sharma, Fulvio Lonardo, Arun K. Rishi, Adhip P.N. Majumdar, Q. Ping Dou, Michele Carbone, John C. Ruckdeschel, Harvey I. Pass	1
19	Disulfiram, a clinically used anti-alcoholism drug and copper-binding agent, induces apoptotic cell death in breast cancer cultures and xenografts via inhibition of the proteasome activity. 2006 ·Cancer Epidemiology and Prevention Biomarkers ·Di Chen, Qiuzhi Cindy Cui, Huanjie Yang, Q. Ping Dou	17
20	Clioquinol and pyrrolidine dithiocarbamate complex with copper to form proteasome inhibitors and apoptosis inducers in human breast cancer cells 2005 ·Breast Cancer Research ·Kenyon G. Daniel, Di Chen, (unknown), Qiuzhi Cindy Cui, Fred R. Miller, Q. Ping Dou	286

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact